Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Sunshine Biopharma Inc banner

Sunshine Biopharma Inc
NASDAQ:SBFM

Watchlist Manager
Sunshine Biopharma Inc Logo
Sunshine Biopharma Inc
NASDAQ:SBFM
Watchlist
Price: 1.1901 USD -0.83%
Market Cap: $5.8m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

SBFM Price Targets Summary
Sunshine Biopharma Inc

Wall Street analysts forecast SBFM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SBFM is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

SBFM Lowest Forecast
Wall Street Target
6.06 USD
409% Upside
SBFM Average Forecast
Wall Street Target
6.12 USD
414% Upside
SBFM Highest Forecast
Wall Street Target
6.3 USD
429% Upside
Lowest
Price Target
6.06 USD
409% Upside
Average
Price Target
6.12 USD
414% Upside
Highest
Price Target
6.3 USD
429% Upside
Sunshine Biopharma Inc Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
24% Upside
MEDP
Medpace Holdings Inc
4% Upside
S
SANA
Sana Biotechnology Inc
113% Upside
ZEAL
Zealand Pharma A/S
71% Upside
PTGX
Protagonist Therapeutics Inc
24% Upside
MEDP
Medpace Holdings Inc
4% Upside
S
SANA
Sana Biotechnology Inc
113% Upside
ZEAL
Zealand Pharma A/S
71% Upside
WASH
Washington Trust Bancorp Inc
-5% Downside

Revenue
Forecast

N/A
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Sunshine Biopharma Inc's revenue for the next 2 years is 21%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

See Also

Summary
SBFM intrinsic value, competitors valuation, and company profile.
DCF Valuation
SBFM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SBFM stock valuation using valuation multiples.
Wall Street Estimates
SBFM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SBFM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SBFM's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for SBFM is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

What is Sunshine Biopharma Inc's Revenue forecast?
Projected CAGR
21%

The compound annual growth rate of Sunshine Biopharma Inc's revenue for the next 2 years is 21%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.